Search Results for “E_S4HCON2023 Übungsmaterialien – E_S4HCON2023 Lernführung: SAP Certified Technology Specialist – SAP S/4HANA Conversion and SAP System Upgrade – E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung” – Page 26

Acquired cold urticaria: clinical picture and update on diagnosis and treatment

18.	Siebenhaar, F., Weller, K., Młynek, A., Magerl, M., Altrichter, S., Vieira dos Santos, R., Maurer, M., and Zuberbier, T.: Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin. Exp. Dermatol. 2007: 32; 241-245. IF: 1.52

152	Maurer, M. Rosén, K.+, Hsie, H. J., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., and Casale, T.: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. New Engl. J. Med. 2013: 368; 924-935. IF: 54.40

In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging

399.

Kröger, M., Scheffel, J., Nikolaev, V. V., Shirshin, E. A., Siebenhaar, F., Schleusener, J., Lademann, J., Maurer, M., and Darvin, M. E.⁺: In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging. Sci. Rep. 2020: 10; 14930. IF: 4.38

o.399

162	Maurer, M.+, Magerl, M., Metz, M., Siebenhaar, F., Weller, K., and Krause, K.: Practical algorithm for diagnosing patients with recurrent wheals or angioedema. Allergy 2013: 68; 816-819. IF: 5.99

166	Siebenhaar, F.+, Förtsch, A., Krause, K., Weller, K., Metz, M., Magerl, M., Martus, P., Church, M. K., and Maurer, M.: Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial. Allergy 2013: 68; 949-952. IF: 5.99

40	Maurer, M. and Siebenhaar, F.: Mastocytosis. In: Plewig, G., Landthaler, M., Burgdorf, W., Hertl, M. and Ruzicka, T., editors: Braun-Falco’s Dermatology. 4. ed., Heidelberg: Springer, 2020.

bc.40

132.	Siebenhaar, F., Redegeld, F. A., Bischoff, S. C., Gibbs, B. F., and Maurer, M.+: Mast cells drivers of disease and therapeutic targets. Trends Immunol. 2018: 39; 151-162. IF: 13.00

104	Metz, M., Altrichter, S., Ardelean, E., Keßler, B., Krause, K., Magerl, M., Siebenhaar, F., Weller, K., Zuberbier, T., and Maurer, M.+: Anti-immunglobulin E treatment of patients with recalcitrant physical urticaria. Int. Arch. Allergy Immunol. 2011: 154; 177-180. IF: 2.40

27	Botchkarev, V. A., Komarova, E. A., Siebenhaar, F., Botchkareva, N. V., Komarov, P. G., Maurer, M. Gilchrest, B. A., and Gudkov, A. V.⁺: p53 is essential for chemotherapy-induced hair loss. Cancer Res. 2000: 60; 5002-5006. IF: 8.46

o.027

28	Botchkarev, V. A.⁺, Komarova, E. A, Siebenhaar, F., Botchkareva, N. V., Sharov, A. A., Komarov, P. G., Maurer. M., Gudkov, A. V., and Gilchrest, B. A.: p53 involvement in the control of murine hair follicle regression. Am. J. Pathol. 2001: 158; 1913-1919. IF: 7.1

o.028

Results

Acquired cold urticaria: clinical picture and update on diagnosis and treatment

Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria

In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging

Practical algorithm for diagnosing patients with recurrent wheals or angioedema

Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial

Mastocytosis

Mast cells drivers of disease and therapeutic targets

Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria

p53 Is Essential for Chemotherapy-induced Hair Loss

p53 Involvement in the Control of Murine Hair Follicle Regression